BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1622396)

  • 1. Effects of calmodulin antagonists on antibody binding to calmodulin. Distinct conformers of calmodulin induced by the binding of drugs.
    Orosz F; Liliom K; Barkhudaryan NA; Horváth L; Ovádi J
    Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):803-8. PubMed ID: 1622396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calmodulin is a potent target for new hypothalamic neuropeptides.
    Horváth L; Barkhudaryan N; Galoyan AA; Ovádi J
    FEBS Lett; 1990 Dec; 276(1-2):197-200. PubMed ID: 2265701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature of the trifluoperazine binding sites on calmodulin and troponin-C.
    Dalgarno DC; Klevit RE; Levine BA; Scott GM; Williams RJ; Gergely J; Grabarek Z; Leavis PC; Grand RJ; Drabikowski W
    Biochim Biophys Acta; 1984 Dec; 791(2):164-72. PubMed ID: 6509062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal ion and drug binding to proteolytic fragments of calmodulin: proteolytic, cadmium-113, and proton nuclear magnetic resonance studies.
    Thulin E; Andersson A; Drakenberg T; Forsén S; Vogel HJ
    Biochemistry; 1984 Apr; 23(8):1862-70. PubMed ID: 6722127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous binding of drugs with different chemical structures to Ca2+-calmodulin: crystallographic and spectroscopic studies.
    Vertessy BG; Harmat V; Böcskei Z; Náray-Szabó G; Orosz F; Ovádi J
    Biochemistry; 1998 Nov; 37(44):15300-10. PubMed ID: 9799490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative evaluation of indirect ELISA. Effect of calmodulin antagonists on antibody binding to calmodulin.
    Liliom K; Orosz F; Horváth L; Ovádi J
    J Immunol Methods; 1991 Sep; 143(1):119-25. PubMed ID: 1919032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sites of interaction of calmodulin with trifluoperazine and glucagon.
    Steiner RF; Marshall L
    Arch Biochem Biophys; 1985 Jul; 240(1):297-311. PubMed ID: 4015106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of the drug-binding sites of calmodulin.
    Zimmer M; Hofmann F
    Eur J Biochem; 1987 Apr; 164(2):411-20. PubMed ID: 3032617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of calcium dissociation from calmodulin and its tryptic fragments. A stopped-flow fluorescence study using Quin 2 reveals a two-domain structure.
    Martin SR; Andersson Teleman A; Bayley PM; Drakenberg T; Forsen S
    Eur J Biochem; 1985 Sep; 151(3):543-50. PubMed ID: 4029146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissimilar mechanisms of action of anticalmodulin drugs: quantitative analysis.
    Orosz F; Telegdi M; Liliom K; Solti M; Korbonits D; Ovádi J
    Mol Pharmacol; 1990 Dec; 38(6):910-6. PubMed ID: 2147457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 113Cd and 1H NMR study of the interaction of calmodulin with D600, trifluoperazine and some other hydrophobic drugs.
    Andersson A; Drakenberg T; Thulin E; Forsén S
    Eur J Biochem; 1983 Aug; 134(3):459-65. PubMed ID: 6884343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calmodulin antagonists' binding sites on calmodulin.
    Tanaka T; Ohmura T; Hidaka H
    Pharmacology; 1983; 26(5):249-57. PubMed ID: 6304789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structurally distinct mammalian calmodulins.
    Zuklys K; Kramer J; Magócsi M; Ovádi J
    Immunol Lett; 1990 May; 24(2):87-92. PubMed ID: 2141325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theoretical studies of the binding of trifluoperazine derivatives to site (82-93) of calmodulin: effect of lengthenings of the methylene linker chain on the binding affinity.
    Gresh N
    Mol Pharmacol; 1987 Jun; 31(6):617-22. PubMed ID: 3600606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive binding assay for drugs that interfere with calmodulin function.
    Le Vine H; Sahyoun N; Cuatrecasas P
    Anal Biochem; 1985 Nov; 151(1):153-8. PubMed ID: 4091274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two trifluoperazine-binding sites on calmodulin predicted from comparative molecular modeling with troponin-C.
    Strynadka NC; James MN
    Proteins; 1988; 3(1):1-17. PubMed ID: 3375233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor and peptide binding to calmodulin characterized by high pressure Fourier transform infrared spectroscopy and Förster resonance energy transfer.
    Cinar S; Czeslik C
    Biochim Biophys Acta Proteins Proteom; 2018; 1866(5-6):617-623. PubMed ID: 29555454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase activating polypeptide is a potent calmodulin inhibitor.
    Au TK; Leung PC
    Biochem Biophys Res Commun; 1995 Mar; 208(1):280-6. PubMed ID: 7887941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-calmodulin potency of indol alkaloids in in vitro systems.
    Molnár A; Liliom K; Orosz F; Vértessy BG; Ovádi J
    Eur J Pharmacol; 1995 Oct; 291(2):73-82. PubMed ID: 8566178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of trifluoperazine and fluorene-containing compounds to calmodulin and adducts.
    Jackson AE; Puett D
    Biochem Pharmacol; 1986 Dec; 35(24):4395-400. PubMed ID: 3790160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.